BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21889446)

  • 1. Hemagglutinin fusion peptide mutants in model membranes: structural properties, membrane physical properties, and PEG-mediated fusion.
    Haque ME; Chakraborty H; Koklic T; Komatsu H; Axelsen PH; Lentz BR
    Biophys J; 2011 Sep; 101(5):1095-104. PubMed ID: 21889446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single mutation effects on conformational change and membrane deformation of influenza hemagglutinin fusion peptides.
    Li J; Das P; Zhou R
    J Phys Chem B; 2010 Jul; 114(26):8799-806. PubMed ID: 20552971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depth-Dependent Membrane Ordering by Hemagglutinin Fusion Peptide Promotes Fusion.
    Chakraborty H; Lentz BR; Kombrabail M; Krishnamoorthy G; Chattopadhyay A
    J Phys Chem B; 2017 Feb; 121(7):1640-1648. PubMed ID: 28125233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties and structures of the influenza and HIV fusion peptides on lipid membranes: implications for a role in fusion.
    Haque ME; Koppaka V; Axelsen PH; Lentz BR
    Biophys J; 2005 Nov; 89(5):3183-94. PubMed ID: 16183890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermodynamics of fusion peptide-membrane interactions.
    Li Y; Han X; Tamm LK
    Biochemistry; 2003 Jun; 42(23):7245-51. PubMed ID: 12795621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane structures of the hemifusion-inducing fusion peptide mutant G1S and the fusion-blocking mutant G1V of influenza virus hemagglutinin suggest a mechanism for pore opening in membrane fusion.
    Li Y; Han X; Lai AL; Bushweller JH; Cafiso DS; Tamm LK
    J Virol; 2005 Sep; 79(18):12065-76. PubMed ID: 16140782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of gp41 fusion peptide on the kinetics of poly(ethylene glycol)-mediated model membrane fusion.
    Haque ME; Lentz BR
    Biochemistry; 2002 Sep; 41(35):10866-76. PubMed ID: 12196026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hemagglutinin fusion peptide on poly(ethylene glycol)-mediated fusion of phosphatidylcholine vesicles.
    Haque ME; McCoy AJ; Glenn J; Lee J; Lentz BR
    Biochemistry; 2001 Nov; 40(47):14243-51. PubMed ID: 11714278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the N-terminal glycine on the secondary structure, orientation, and interaction of the influenza hemagglutinin fusion peptide with lipid bilayers.
    Gray C; Tatulian SA; Wharton SA; Tamm LK
    Biophys J; 1996 May; 70(5):2275-86. PubMed ID: 9172751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Line-tension controlled mechanism for influenza fusion.
    Risselada HJ; Marelli G; Fuhrmans M; Smirnova YG; Grubmüller H; Marrink SJ; Müller M
    PLoS One; 2012; 7(6):e38302. PubMed ID: 22761674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Interaction between Influenza HA Fusion Peptide and Transmembrane Domain Affects Membrane Structure.
    Lai AL; Freed JH
    Biophys J; 2015 Dec; 109(12):2523-2536. PubMed ID: 26682811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wild-type and mutant hemagglutinin fusion peptides alter bilayer structure as well as kinetics and activation thermodynamics of stalk and pore formation differently: mechanistic implications.
    Chakraborty H; Tarafdar PK; Klapper DG; Lentz BR
    Biophys J; 2013 Dec; 105(11):2495-506. PubMed ID: 24314080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-dependent self-association of influenza hemagglutinin fusion peptides in lipid bilayers.
    Han X; Tamm LK
    J Mol Biol; 2000 Dec; 304(5):953-65. PubMed ID: 11124039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane interactions of mutated forms of the influenza fusion peptide.
    Epand RM; Epand RF; Martin I; Ruysschaert JM
    Biochemistry; 2001 Jul; 40(30):8800-7. PubMed ID: 11467940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-induced conformational changes of membrane-bound influenza hemagglutinin and its effect on target lipid bilayers.
    Gray C; Tamm LK
    Protein Sci; 1998 Nov; 7(11):2359-73. PubMed ID: 9828002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transmembrane domain peptide of vesicular stomatitis virus promotes both intermediate and pore formation during PEG-mediated vesicle fusion.
    Sengupta T; Chakraborty H; Lentz BR
    Biophys J; 2014 Sep; 107(6):1318-26. PubMed ID: 25229140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of mutant influenza virus hemagglutinin fusion peptides with lipid bilayers: probing the role of hydrophobic residue size in the central region of the fusion peptide.
    Han X; Steinhauer DA; Wharton SA; Tamm LK
    Biochemistry; 1999 Nov; 38(45):15052-9. PubMed ID: 10555988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary structure, orientation, oligomerization, and lipid interactions of the transmembrane domain of influenza hemagglutinin.
    Tatulian SA; Tamm LK
    Biochemistry; 2000 Jan; 39(3):496-507. PubMed ID: 10642174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin.
    Han X; Bushweller JH; Cafiso DS; Tamm LK
    Nat Struct Biol; 2001 Aug; 8(8):715-20. PubMed ID: 11473264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 1-127 HA2 construct of influenza virus hemagglutinin induces cell-cell hemifusion.
    Leikina E; LeDuc DL; Macosko JC; Epand R; Epand R; Shin YK; Chernomordik LV
    Biochemistry; 2001 Jul; 40(28):8378-86. PubMed ID: 11444985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.